Improving and Evaluation of a New Cross-sectoral Hospital at Home Model for Elderly Acute Ill Patients

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Many elderly patients with uncomplicated treatment courses are admitted unnecessarily, which is a burden for the patient and society. Studies show that Hospital at Home (HaH) treatment is an alternative to hospitalization. The patient's risk of delirium, infection and loss of function is reduced when the patient avoids the hospital stay. HaH treatment is expected to be more cost-effective, improve patients' functional abilities and patients' satisfaction. Three municipalities, general practitioners, pre-hospital service and an emergency department (ED) in Central Denmark Region have organized the first HaH treatment model across disciplines and sectors. Specialists in the ED and the municipal acute teams provide HaH treatment for elderly acute ill patients. However, the model has not yet been evaluated. The aim of this study is to optimize the HaH treatment model for elderly acute ill patients. The objective is to increase patient satisfaction and optimize the use of resources in healthcare by avoiding unnecessary hospitalizations that impair and prolong treatment. This study is an open label randomized controlled trial (RCT) with a 1:2 allocation ratio of acute hospital admission versus HaH. During a pilot period, we tested and adapted the patient pathway of HaH to the practical reality, before we start the randomization for the RCT study. We will investigate the clinical effects and health economic consequences of HaH treatment compared with standard hospital treatment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: f
View:

• The patient should be aged 65 and over

• Diagnosed with a stable acute medical conditions e.g. cystitis, erysipelas, pneumonia

• The patient should be living in their own home or a nursing home before entering the study

• The patient should be residing in one of the three municipalities (Viborg, Skive and Silkeborg)

• The patient must have been seen by the GP or the pre-hospital service in the case of disease in question

• The patient should speak and understand Danish.

• The patient should give informed consent to participate in the study.

Locations
Other Locations
Denmark
Silkeborg municipality
RECRUITING
Silkeborg
Skive municipality
RECRUITING
Skive
Viborg municipality
RECRUITING
Viborg
Contact Information
Primary
Camilla Palmhøj Nielsen, Ph.D
camilla.palmhoj@rm.dk
+4521621238
Time Frame
Start Date: 2022-06-01
Estimated Completion Date: 2027-08
Participants
Target number of participants: 849
Treatments
Experimental: Hospital at Home (HaH) treatment
The patients in this arm will receive the intervention.
Active_comparator: Standard hospital admission
The patients in this arm are the control group and will receive the standard hospital treatment.
Sponsors
Leads: Defactum, Central Denmark Region
Collaborators: Viborg Regional Hospital, Research Center for Emergency Medicine, Aarhus University, Denmark, Interdisciplinary Centre for Organizational Architecture (ICOA), Aarhus University, Denmark

This content was sourced from clinicaltrials.gov